CIK 0001140859
- Large accelerated filer
Cencora, Inc.
Sign in to watch- Ticker
- COR
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 233079390
- Phone
- +1 610-727-7000
- Business address
- 1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428
- Former names
- AMERISOURCEBERGEN CORP, AMERISOURCE BERGEN CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,020,270
- in 5 filings, $946K under 10b5-1 plans
Net −$5,020,270. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-01 | HYLE KATHLEEN W Director | Exercise or conversion · Restricted Stock Units | −1,340 | 0 | ||
| 2021-03-01 | HENNEY JANE E MD Director | Exercise or conversion | +1,608 | 19,984 | ||
| 2021-03-01 | HENNEY JANE E MD Director | Exercise or conversion · Restricted Stock Units | −1,608 | 0 | ||
| 2021-03-01 | GOCHNAUER RICHARD W Director | Exercise or conversion | +1,340 | 15,522 | ||
| 2021-03-01 | GOCHNAUER RICHARD W Director | Exercise or conversion · Restricted Stock Units | −1,340 | 0 | ||
| 2021-02-12 | Chou John G. Executive Vice President | Gift | −2,000 | 67,101 | ||
| 2021-02-10 | COLLIS STEVEN H Chairman, President & CEO | Exercise or conversion | +1,419 | $88.71 | $126K | 199,476 |
| 2021-02-10 | COLLIS STEVEN H Chairman, President & CEO | Sale | −1,419 | $108.08 | $153K | 198,057 |
| 2021-02-10 | COLLIS STEVEN H Chairman, President & CEO | Exercise or conversion · Non-qualified Stock Option (Right to Buy) | −1,419 | 112,000 | ||
| 2021-02-08 | HYLE KATHLEEN W Director | Exercise or conversion | +3,085 | $37.43 | $115K | 15,477 |
| 2021-02-08 | HYLE KATHLEEN W Director | Sale | −3,085 | $108.79 | $336K | 12,392 |
| 2021-02-08 | HYLE KATHLEEN W Director | Exercise or conversion · Non-qualified Stock Option (Right to Buy) | −3,085 | 0 | ||
| 2021-02-08 | COLLIS STEVEN H Chairman, President & CEO | Exercise or conversion | +700 | $88.71 | $62K | 198,757 |
| 2021-02-08 | COLLIS STEVEN H Chairman, President & CEO | Sale | −700 | $110.08 | $77K | 198,057 |
| 2021-02-08 | COLLIS STEVEN H Chairman, President & CEO | Exercise or conversion · Non-qualified Stock Option (Right to Buy) | −700 | 113,419 | ||
| 2021-02-05 | COLLIS STEVEN H Chairman, President & CEO | Exercise or conversion | +73,951 | $88.71 | $6.6M | 282,008 |
| 2021-02-05 | COLLIS STEVEN H Chairman, President & CEO | Sale | −83,951 | $110.36 | $9.3M | 198,057 |
| 2021-02-05 | COLLIS STEVEN H Chairman, President & CEO | Exercise or conversion · Non-qualified Stock Option (Right to Buy) | −73,951 | 114,119 | ||
| 2021-02-02 | DURCAN DERMOT MARK Director | Grant or award | +292 | $106.89 | $31K | 8,008 |
| 2021-02-02 | NALLY DENNIS M Director | Grant or award | +234 | $106.89 | $25K | 780 |
Page 60 of 68 · 1,355 trades